Cargando…

Metabolic Control in Type 1 Diabetes: Is Adjunctive Therapy the Way Forward?

Despite advances in insulin therapies, patients with type 1 diabetes (T1DM) have a shorter life span due to hyperglycaemia-induced vascular disease and hypoglycaemic complications secondary to insulin therapy. Restricting therapy for T1DM to insulin replacement is perhaps an over-simplistic approach...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warnes, Harriet, Helliwell, Rebecca, Pearson, Sam Matthew, Ajjan, Ramzi A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167310/ https://www.ncbi.nlm.nih.gov/pubmed/30209797 http://dx.doi.org/10.1007/s13300-018-0496-z

Ejemplares similares

Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date
por: Pearson, Sam, et al.
Publicado: (2019)

Risk factors associated with mortality in individuals with type 2 diabetes following an episode of severe hypoglycaemia. Results from a randomised controlled trial
por: Pearson, Sam M, et al.
Publicado: (2022)

Estimated glucose disposal rate demographics and clinical characteristics of young adults with type 1 diabetes mellitus: A cross-sectional pilot study
por: Nishtala, Revathi, et al.
Publicado: (2020)

Reduction in cardiovascular mortality following severe hypoglycemia in individuals with type 2 diabetes: the role of a pragmatic and structured intervention: Structured intervention for community hypoglycemia
por: Pearson, Sam M., et al.
Publicado: (2021)

The relative contribution of diurnal and nocturnal glucose exposures to HbA1c in type 1 diabetes males: a pooled analysis
por: Campbell, Matthew D., et al.
Publicado: (2022)

Glucose variability is associated with an adverse vascular profile but only in the presence of insulin resistance in individuals with type 1 diabetes: An observational study
por: Kietsiriroje, Noppadol, et al.
Publicado: (2022)

Small steps forward: Adjunctive therapy for T1D
por: Bloomgarden, Zachary, et al.
Publicado: (2022)

Adjunctive therapy for glucose control in patients with type 1 diabetes
por: Harris, Kira, et al.
Publicado: (2018)

The Way Forward Is the Way Back
por: Potter, Polyxeni
Publicado: (2007)

The way forward
Publicado: (2002)

The Way Forward
por: Singh, Yamuna
Publicado: (2020)

The Way Forward
Publicado: (2005)

HPV prevention and control – The way forward
por: Vorsters, Alex, et al.
Publicado: (2022)

Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels
por: Parker, William A. E., et al.
Publicado: (2020)

Lipidomic profiling of plasma free fatty acids in type-1 diabetes highlights specific changes in lipid metabolism
por: Sobczak, Amélie I.S., et al.
Publicado: (2021)

The current state of SUSY and ways forward
por: Reece, Matthew, et al.
Publicado: (2021)

Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: A pilot, multicentre, randomised controlled trial
por: Ajjan, Ramzi A, et al.
Publicado: (2019)

Cost-Effectiveness Analysis of Flash Glucose Monitoring System for People with Type 2 Diabetes Receiving Intensive Insulin Treatment
por: Ajjan, Ramzi, et al.
Publicado: (2022)

Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets
por: Pechlivani, Nikoletta, et al.
Publicado: (2018)

Which Way Forward
por: Colfer, Carol
Publicado: (2010)

Endocrinology: The Way Forward
por: Chadha, Manoj
Publicado: (2018)

Non-Traditional Pathways for Platelet Pathophysiology in Diabetes: Implications for Future Therapeutic Targets
por: Sagar, Rebecca C., et al.
Publicado: (2022)

Controlling Johne's disease: vaccination is the way forward
por: Bannantine, John P., et al.
Publicado: (2015)

A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic control
por: Parker, William A. E., et al.
Publicado: (2021)

Iron and Malaria Interactions: Programmatic Ways Forward
por: Stoltzfus, Rebecca J.
Publicado: (2012)

Creativity and diabetes education: Essentiality, impact and way forward
por: Sarda, Archana
Publicado: (2015)

Emerging health care technologies in diabetes: is it the way forward?
por: Chawla, Rajeev
Publicado: (2023)

SGLT inhibitor adjunct therapy in type 1 diabetes
por: McCrimmon, Rory J., et al.
Publicado: (2018)

Value-Based Care in Systemic Therapy: The Way Forward
por: Mathew, Aju, et al.
Publicado: (2022)

Pulmonary fibrosis: Is stem cell therapy the way forward?
por: Ikrama, Muhammad, et al.
Publicado: (2023)

Pharmacokinetic–Pharmacometabolomic Approach in Early-Phase Clinical Trials: A Way Forward for Targeted Therapy in Type 2 Diabetes
por: Tee, Khim Boon, et al.
Publicado: (2022)

Total plasma magnesium, zinc, copper and selenium concentrations in type-I and type-II diabetes
por: Sobczak, Amélie I. S., et al.
Publicado: (2019)

Reappraisal of PRRS Immune Control Strategies: The Way Forward
por: Amadori, Massimo, et al.
Publicado: (2021)

Automated quantification of 3D wound morphology by machine learning and optical coherence tomography in type 2 diabetes
por: Wang, Yinhai, et al.
Publicado: (2022)

The Role of Adjunctive Exenatide Therapy in Pediatric Type 1 Diabetes
por: Raman, Vandana S., et al.
Publicado: (2010)

PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target
por: Altalhi, Rawan, et al.
Publicado: (2021)

The three Rs: the way forward.
por: Zurlo, J, et al.
Publicado: (1996)

Bt technology -the way forward
por: Valicente, Fernando
Publicado: (2014)

Right to Healthcare: The Way Forward
por: Peer, Rafia F.
Publicado: (2013)

Mitochondria sense the way forward
por: Sedwick, Caitlin
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jhn2q7v4c19ahtpm109kfhbfj3